Gain Therapeutics Price Target Maintained With a $8.00/Share by HC Wainwright & Co.
DO Dow Jones Newswires Gain Therapeutics Price Target Maintained With a $8.00/Share by HC Wainwright & Co. 7/1/2026, 07:56 PM GMT+8 Dow Jones Newswires GA GANX Gain Therapeutics Price Target Maintained With a $8.00/Share by HC Wainwright & Co. Market News Dow Jones Newswires Gain Therapeutics Is Maintained at Buy by BTIG Stocktwits Why Is GANX Stock Rallying 22% After Hours? Dow Jones Newswires Gain Therapeutics Gets FDA Approval to Start Phase 2 Study of Parkinson's Drug Dow Jones Newswires Gain Therapeutics Gets FDA Approval to Start Phase 2 Study of Parkinson's Drug
